Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Our work and case studies


To rapidly manufacture a GMP-compliant API-in-capsule product for use in Phase I and Phase II clinical trials.  The product was being investigated for treatments spanning multiple therapeutic areas.


Japanese Speciality Pharma


Precision filling and dispensing of API into capsules was achieved using semi-automatic, automatic and robotic capsule filling equipment. Full QC Testing, QA release and QP certification, shipment service and CMC Dossier Compilation were completed by the Arcinova team to synergistically reduce project timelines.  Phase I and Phase II clinical trials were successfully implemented, exceeding clients predicted timelines by a factor of two.


Accelerated Development to Clinical Studies Rapid Manufacture - Precision Filling Case Study